Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 48 Results Clear All
Scientific American recognizes Theodoris for her pioneering work developing artificial intelligence models to find treatments for an array of diseases.
Gladstone scientists have developed a thinking microscope that can conduct its own experiments, with the ultimate goal of treating neurodegenerative diseases.
Finkbeiner Lab AI Center for Systems and Therapeutics Neurological Disease Alzheimer’s Disease Parkinson’s Disease ALS Huntington’s DiseaseGladstone scientists have developed a thinking microscope powered by artificial intelligence.
AI Finkbeiner Lab Neurological Disease Center for Systems and Therapeutics Alzheimer’s Disease Parkinson’s Disease ALSThe center, funded by an NIH grant, will become one of three national centers dedicated to accelerating the development of phage therapy.
News Release Grants Data Science and Biotechnology Infectious Disease Shipman Lab Pollard Lab Ott Lab Silas Lab AIA new study upends long-held view about how DNA is stored, explaining how subtle shifts in gene activity contribute to cancer, aging, and other complex diseases.
News Release Research (Publication) Cancer Data Science and Biotechnology Ramani Lab Aging AIGladstone scientists are developing novel AI models to predict what goes wrong in disease—and how to fix it.
Theodoris Lab AI Cardiovascular DiseaseHow do brain cells change with age? How are liver cells impacted when someone takes a new medicine? What happens to lung cells after decades of smoking?
Cardiovascular Disease Theodoris Lab AIThe prize, issued annually to eight scientists, seeks to catalyze high-impact neuroscience research.
Awards News Release Alzheimer’s Disease Neurological Disease Corces Lab AITrained on data spanning the human lifespan, a new tool developed at Gladstone can predict genes associated with aging and age-related diseases.
News Release Research (Publication) Cardiovascular Disease Theodoris Lab Aging AIGladstone Institutes is adding state-of-the-art laboratories in a newly constructed Mission Bay building.
History Institutional News News Release Genomic Immunology Data Science and Biotechnology Marson Lab Pollard Lab AI CRISPR/Gene Editing GenomicsScientists at Gladstone are combining AI models with cutting-edge lab tools to finally make sense of the human genome.
AI Srivastava Lab Pollard Lab Engelhardt Lab Theodoris Lab Shipman Lab Ramani Lab Finkbeiner Lab Cardiovascular Disease Neurological DiseaseIn this video, Katie Pollard and Deepak Srivastava explain how Gladstone scientists are combining AI models with novel tools in the lab to finally decode the entire human genome.
Gladstone Experts Pollard Lab Srivastava Lab AIGladstone scientists are developing new AI tools that promise to revolutionize how science is done and lead to new treatments for the most devastating diseases.
AI Srivastava Lab Pollard Lab Engelhardt Lab Theodoris Lab Shipman Lab Ramani Lab Finkbeiner Lab Cardiovascular Disease Neurological DiseaseSLAS—Steve Finkbeiner, director of the Center for Systems and Therapeutics, was selected as the recipient of the 2026 Innovation Award by the Society for Laboratory Automation and Screening for his work on AI, robotics, and the thinking microscope.
Gladstone Experts Finkbeiner Lab AI Robotic Microscopy